1 / 15

Molecular Diagnostics Market to Cross US$ 10 Billion by 2021

The molecular diagnostics market is expected to exceed more than US$ 10 Billion by 2021 growing at around 9% CAGR during the forecast period.

wamy156
Télécharger la présentation

Molecular Diagnostics Market to Cross US$ 10 Billion by 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Diagnostics Market Research Report Presented By Market Research Engine https://www.marketresearchengine.com/

  2. Report TitleMolecular Diagnostics Market to Cross US$ 10 Billion by 2021 - by Market Research Engine

  3. New York, November 12: Market Research Engine has published a new report titled as “Molecular Diagnostics Market by Application, Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2023” The molecular diagnostics market is expected to exceed more than US$ 10 Billion by 2021 growing at around 9% CAGR during the forecast period. Download Free Sample Report: https://www.marketresearchengine.com/requestsample/molecular-diagnostics-market Molecular diagnostics is a technique used to analyse, diagnose, monitor and treat disease. Using molecular diagnostics process it identify a disease by examining different molecules such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), protein and in tissue. Molecular diagnostics are primarily used for healthcare diagnosis and also used for research purpose. Molecular diagnostics provide more accurate results and they are playing a vital role in health care system.

  4. The main driving factors for molecular diagnostics market are increased awareness and usage of personalized medicine. The companion diagnostics will grow eventually with growth of personalized medicine which in turn will drive the molecular diagnostics products and services market. It contains high prevalence rate of infectious diseases and various types of cancer. The new biomarkers are developed using molecular techniques which are applied in molecular diagnostics. It increases the growth in proteomics and genomics research.The molecular diagnostics market has some restraints such as it require new tools which contain complex platforms which require skilled and experienced workers. Because of mandatory training and complex regulatory framework gives delay approvals of new molecular diagnostic tests. Browse Full Report:https://www.marketresearchengine.com/reportdetails/molecular-diagnostics-market The molecular diagnostics market is segmented by product, by technology, by application and by end user analysis. Under the product and service segmentation it contains instruments, reagents and services & software.

  5. It uses different technologies such as polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA sequencing and next-generation sequencing, microarrays, mass pectrometry, flow cytometry, and electrophoresis. Molecular diagnostics techniques are used in different application such as infectious diseases, oncology, genetics, blood screening, microbiology, cardiovascular diseases, neurological diseases, and DNA fingerprinting. The end user of molecular diagnostics are reference laboratories, hospital laboratories, blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing. The molecular diagnostics market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: 1) An overview of the global market for molecular diagnostics and related technologies.2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.

  6. 3) Identifications of new market opportunities and targeted promotional plans for molecular diagnostics.4) Discussion of research and development, and the demand for new products and new applications.5) Comprehensive company profiles of major players in the industry. REPORT SCOPE:The scope of the report includes a detailed study of global and regional markets for various types of molecular diagnostics with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid Inc. (U.S.).

  7. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. The Molecular diagnostics Market has been segmented as below:  By Product and service Segment AnalysisInstrumentsReagentsServices & SoftwareBy Technology AnalysisPolymerase Chain Reaction (PCR)Isothermal Nucleic Acid Amplification Technology (INAAT)Hybridization DNA Sequencing and Next-generation Sequencing

  8. Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)By Regional AnalysisNorth AmericaEuropeAsia-PacificRest of the World Reasons to buy this Report: 1) Obtain the most up to date information available on all active and planned molecular diagnostics industry globally.2) Identify growth segments and opportunities in the industry.3) Facilitate decision making on the basis of strong historic and forecast of molecular diagnostics industry and unit capacity data.4) Assess your competitor’s refining portfolio and its evolution.

  9. Table of Contents Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions Chapter 2 Executive Summary 2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019) 2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million) Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Rising incidence of cancer cases

  10. 3.2.2 Aging population 3.2.3 Increase in incidence of chronic diseases 3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines 3.3 Market Restraints 3.3.1 Issues with reimbursement policies 3.4 Market Opportunities 3.4.1 Technological advancements 3.4.2 Tapping the emerging economies 3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of New Entrants 3.5.4 Threat of Substitutes 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography Chapter 4 Molecular Diagnostics Market, by Technology 4.1 Overview 4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 4.2 Polymerase Chain Reaction (PCR)

  11. 4.2.1 Global PCR Market, 2011 – 2019 (USD Million) 4.3 Transcription Mediated Amplification (TMA) 4.3.1 Global TMA Market, 2011 – 2019 (USD Million) 4.4 Microarray 4.4.1 Global Microarray Market, 2011 – 2019 (USD Million) 4.5 Hybridization (ISH and FISH) 4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million) 4.6 Next-generation sequencing 4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million) 4.7 Others 4.7.1 Global Others Market, 2011 – 2019 (USD Million) Chapter 5 Global Molecular Diagnostics Market, by Applications 5.1 Overview 5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million) 5.2 Infectious Diseases 5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million) 5.2.2 Virology 5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million)

  12. 5.2.2.2 Human immunodeficiency virus (HIV) testing 5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million) 5.2.2.3 Human papillomavirus (HPV) testing 5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million) 5.2.2.4 Hepatitis C virus (HCV) testing 5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million) 5.2.2.5 Others 5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.2.3 Bacteriology 5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million) 5.2.3.2 Hospital Acquired Infection (HAI) testing 5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million) 5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing 5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million) 5.2.3.4 Others 5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.3 Genomics 5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million) 5.3.2 Genetic testing for inherited disorders 5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million) 5.3.3 Human Leukocyte Antigen (HLA)testing

  13. 5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million) 5.3.4 Pharmacogenetics testing 5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million) 5.3.5 Oncology testing 5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million) 5.4 Blood Donor Screening 5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million) 5.5 Others 5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)

  14. Check out other Research Reports: Intracranial Pressure Monitors Market by Application (Intracerebral Hemorrhage, Meningitis, Traumatic Brain Injury), by Type (Microtransducer ICP Monitoring Devices, External Ventricular Drainage System & Lumbar Drainage System) – Global Market Analysis and Forecast 2023 https://www.marketresearchengine.com/reportdetails/intracranial-pressure-monitors-market-report Laboratory Information System (LIS) Market by Type (Standalone, Integrated), Delivery Mode (On-premise, Hosted, SaaS), End User Labs (Clinical, Molecular Diagnostic, Blood Bank, Anatomic Pathology) & by Component (Software, Services) - Global Forecast to 2020 https://www.marketresearchengine.com/reportdetails/laboratory-information-systems-market

  15. About Market Research Engine Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. More info: https://www.marketresearchengine.com/ Media Contact: Name: John Bay Toll Free No.: +1-855-984-1862 Phone: +91-860-565-7204 Email:john@marketresearchengine.com Website:https://www.marketresearchengine.com/

More Related